A Non-integrating Lentiviral Approach Overcomes Cas9-Induced Immune Rejection to Establish an Immunocompetent Metastatic Renal Cancer Model
2018 · Molecular Therapy — Methods & Clinical Development · 38 citations
https://doi.org/10.1016/j.omtm.2018.02.009